Mesoblast Limited MESO
Set alert
14.54 USD -0.62 -4.09%
At close · Nov 2
14.61 +0.07 +0.48%
After hours · Nov 2, 4:00 PM ET
14.51 Day range 15.08
11.89 52-week range 21.50
- YTD
- -19.40%
- 1 year
- -12.73%
- Open
- 15.08
- Prev close
- 15.16
- Mkt cap
- 1.89B
- Vol
- 261.31K
- Avg vol
- 235.14K
- EPS
- -0.44
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 14.51
- High
- 15.08
- Forward P/E
- 31.96
- Beta
- 0.91
- Short ratio
- 14.11
- Inst. own
- 3.27%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Mar 4, 2027
- 50-d avg
- 14.93
- 200-d avg
- 15.41
- 1y target
- 37.00
MAX chart
Events in this range
- Jan 5, 2024Split: 1 for 2
- Feb 7, 2025Rating: Piper Sandler · Overweight → Overweight
Signals (59)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Sep 1, 2026 | 2 months ago |
| SMA: Bullish | Aug 1, 2026 | 3 months ago |
| MACD: Sell Signal | Apr 1, 2026 | 7 months ago |
| SMA: Bearish | Mar 1, 2026 | 8 months ago |
| SMA: Bullish | Sep 1, 2025 | 1 year ago |
| SMA: Bearish | Aug 1, 2025 | 1 year ago |
| SMA: Bullish | Jul 1, 2025 | 1 year ago |
| SMA: Bearish | Apr 1, 2025 | 1 year ago |
| RSI: Overbought | Dec 1, 2024 | 1 year ago |
| SMA: Bullish | Apr 1, 2024 | 2 years ago |
| SMA: Bullish | Mar 1, 2024 | 2 years ago |
| MACD: Buy Signal | Mar 1, 2024 | 2 years ago |
| MACD: Sell Signal | Oct 1, 2023 | 3 years ago |
| SMA: Bearish | Aug 1, 2023 | 3 years ago |
| SMA: Bullish | May 1, 2023 | 3 years ago |
| SMA: Bearish | Apr 1, 2023 | 3 years ago |
| SMA: Bullish | Jan 1, 2023 | 3 years ago |
| MACD: Buy Signal | Jan 1, 2023 | 3 years ago |
| SMA: Bearish | Dec 1, 2022 | 3 years ago |
| SMA: Bullish | Nov 1, 2022 | 4 years ago |
Newest 20 of 59.
Analyst view
Consensus: none
Price target (mean) 37.00 +154.5% upside
Now 14.54
- Target (low)
- 35.00
- Target (mean)
- 37.00
- Target (high)
- 39.00
Ratings (0m) 3 3 buy · 0 hold · 0 sell
- Strong buy2
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 3
- 2 months ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.08 | -0.08 – -0.08 | 0.00 | 0.0% | 54.86M | 0.0% | 1 |
| Next quarter | -0.07 | -0.07 – -0.07 | 0.00 | 0.0% | 57.24M | +33.4% | 1 |
| Current year | -0.055 | -0.12 – 0.01 | -0.444 | +87.6% | 254.41M | +51.6% | 2 |
| Next year | 0.455 | 0.36 – 0.55 | -0.055 | +927.3% | 415.69M | +63.4% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 27, 2026 | Piper Sandler | Reiterated | Overweight | Overweight |
| Nov 25, 2025 | Jefferies | Upgrade | Hold | Buy |
| Jul 18, 2025 | Jefferies | Downgrade | Buy | Hold |
| Feb 7, 2025 | Piper Sandler | Reiterated | Overweight | Overweight |
| Dec 23, 2024 | Jefferies | Downgrade | Buy | Hold |
| Dec 19, 2024 | Piper Sandler | Maintained | Overweight | Overweight |
| Jul 23, 2024 | Piper Sandler | Upgrade | Neutral | Overweight |
| Jun 20, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Jun 4, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |